Posted 11/3/2015 1:20 AM (GMT 0)
My dad was on Xtandi, while hormone sensitive. He was on a Lupron+Casodex regimen, and the Casodex was switched to Xtandi.
F18 PET/CT scan showed bone mets, so the oncologist decided it was best to switch to Xtandi, given the greater-than-anticipated disease burden and also the slowing velocity of PSA decline. Basically, he said there is no point in waiting for CRPC to set it, before using the new hormonal agents. They'll be more effective in his case, the sooner he took them.
Dad did Xtandi for 4 months (with continuous PSA declines) and then had to stop it. He was one of the few unlucky ones to experience severe side effects (total loss of appetite, dangerous spikes blood pressure and constant debilitating nausea while attempting to eat and drink). But, it definitely did help in his fight against PC. Now, he's switched to Zytiga, hoping to reach <0.0.01 and a much deserved vacation from HT.
Arthur.